Riskpilot← Back to searchSign inGet full accessCH MEDINVEST ApS
APSActiveCVR 26540879Tjørnevej 6A, 1. thActivities of holding companies · NACE 6421Est. 20021 employees
Revenue 2024
DKK -237K
+49% vs 2023
EBITDA margin
163.8%
+54% vs 2023
Equity ratio
91.9%
Financial strength
Net profit 2024
DKK -1,4M
+46% vs 2023
| Revenue | DKK -237K | +49% |
| EBITDA | DKK -389K | +54% |
| Net profit | DKK -1,4M | +46% |
| Total assets | DKK 18,3M | -14% |
| Equity | DKK 16,9M | -9% |
| Employees | 1 | — |
Legal name
CH MEDINVEST ApS
CVR number
26540879
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
30. januar 2002
Share capital
DKK 125.000
Employees
1 (FTE)
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør.
Company purpose
Selskabets formål er investeringer i udviklingsselskaber, ejendomme, værdipapirer og konsulentarbejde samt al virksomhed, som efter direktionens skøn er beslægtet hermed.
Address
Tjørnevej 6A, 1. th
Phone
+4520462850
Email
ch@ortoinnovation.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | -195 | -269 | -211 | -159 | -237 |
| Staff expenses | -567 | -687 | -564 | -695 | -152 |
| EBITDA | -761 | -956 | -775 | -854 | -389 |
| Depreciation & amort. | -0 | -4 | -5 | -6 | -0 |
| EBIT | -761 | -961 | -780 | -860 | -389 |
| Net financials | 2.857 | 1.018 | 1.809 | 2.666 | -1.117 |
| Profit before tax | 1.096 | 57 | 29 | -2.735 | -1.506 |
| Tax | -120 | -134 | -72 | -73 | -60 |
| Net profit | 1.216 | 191 | 101 | -2.662 | -1.445 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 21.261 | 22.335 | 23.539 | 21.314 | 18.340 |
| Equity | 21.135 | 21.213 | 21.199 | 18.419 | 16.852 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 119 | 1.117 | 2.336 | 2.895 | 1.488 |
| Total debt | 119 | 1.117 | 2.336 | 2.895 | 1.488 |
EBITDA margin
-38893800.0%
This company
15.8%
Market median
-246163391% vs market
20202024
Equity ratio
91.9%
This company
38.2%
Market median
+141% vs market
20202024
Return on equity
-8.6%
This company
18.4%
Market median
-147% vs market
20202024
Net profit margin
-144534400.0%
This company
8.1%
Market median
-1784375409% vs market
20202024
Asset turnover
-0.01×
This company
1.12×
Market median
-101% vs market
20202024
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2002 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CH MEDINVEST ApS 
Equilibrium Diagnostics ApSBoard members of CH MEDINVEST ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|